Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac N.V (CVAC) EBT Margin: 2019-2025

Historic EBT Margin for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -4,816.55%.

  • CureVac N.V's EBT Margin fell 432304.00% to -4,816.55% in Q2 2025 from the same period last year, while for Jun 2025 it was 43.47%, marking a year-over-year increase of 46270.00%. This contributed to the annual value of 35.67% for FY2024, which is 51926.00% up from last year.
  • Per CureVac N.V's latest filing, its EBT Margin stood at -4,816.55% for Q2 2025, which was up 16.73% from -5,784.43% recorded in Q1 2025.
  • CureVac N.V's 5-year EBT Margin high stood at 1,180,978.72% for Q2 2021, and its period low was -991,144.41% during Q4 2021.
  • Moreover, its 3-year median value for EBT Margin was -529.17% (2024), whereas its average is -1,422.28%.
  • Examining YoY changes over the last 5 years, CureVac N.V's EBT Margin showed a top increase of 99,004,399bps in 2022 and a maximum decrease of 118,126,449bps in 2022.
  • Over the past 5 years, CureVac N.V's EBT Margin (Quarterly) stood at -991,144.41% in 2021, then spiked by 99,004,399bps to -1,100.43% in 2022, then surged by 71,774bps to -382.69% in 2023, then surged by 11,675bps to -265.94% in 2024, then crashed by 432,304bps to -4,816.55% in 2025.
  • Its last three reported values are -4,816.55% in Q2 2025, -5,784.43% for Q1 2025, and -265.94% during Q4 2024.